Peer-reviewedLicence not statedPharmacological Reviews
Hunting gremlins: GREM1 as a new therapeutic target for multiple diseases including glaucoma
4 affiliations
- 1Department of Pharmacology and Neuroscience, University of North Texas Health Fort Worth, Fort Worth, Texas
- 2Paul L. Foster School of Medicine, Texas Tech Health El Paso, El Paso, Texas
- 3Burnett School of Medicine, Texas Christian University, Fort Worth, Texas
- 4North Texas Eye Research Institute, University of North Texas Health Fort Worth, Texas
Related
- Special Issue “Molecular Mechanisms and Therapeutic Targets in Skin Diseases”
- Keratinocyte necroptosis in inflammatory skin diseases and acute epidermal injury: mechanisms, evidence, and therapeutic implications
- Deubiquitinases as Regulators and Therapeutic Targets in Vascular Diseases
- Molecular mechanisms, crosstalk and therapeutic potential of novel acylation modifications in cardiovascular and cerebrovascular diseases.
- Cuproptosis: New Mechanisms Linking Endothelial Dysfunction to Neurodegenerative Diseases and Therapeutic Prospects
BibTeX
@article{siderovski2026hunting,
title = {{Hunting gremlins: GREM1 as a new therapeutic target for multiple diseases including glaucoma}},
author = {David P. Siderovski and Nishanth Myneni and Monica Botross and Pinkal D. Patel and Abbot F. Clark},
journal = {Pharmacological Reviews},
year = {2026},
month = jul,
doi = {10.1016/j.pharmr.2026.100152},
url = {https://doi.org/10.1016/j.pharmr.2026.100152},
}
RIS
TY - JOUR
TI - Hunting gremlins: GREM1 as a new therapeutic target for multiple diseases including glaucoma
AU - David P. Siderovski
AU - Nishanth Myneni
AU - Monica Botross
AU - Pinkal D. Patel
AU - Abbot F. Clark
PY - 2026
DA - 2026/07/15
JO - Pharmacological Reviews
DO - 10.1016/j.pharmr.2026.100152
UR - https://doi.org/10.1016/j.pharmr.2026.100152
SN - 0031-6997
SN - 1521-0081
ER -